Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China
Vor Biopharma Inc VOR
$14.49
▼ -3.53%
($-0.53)
Open
$15.18
Prev Close
$15.02
Day Range
$14.38 – $15.44
52W Range
$4.06 – $65.80
Market Cap
$764.56M
Beta
1.66
EPS (TTM)
$-293.09
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-02-05 |
| Shares Out. | 54,190,000 |
| Website | vorbio.com/ ↗ |
| Phone | 16176556580 |
Vor Biopharma Inc is a publicly traded company under the ticker symbol VOR on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-06-01)